The Janus Faces of Bone Morphogenetic Protein 9 in Pulmonary Arterial Hypertension

Circ Res. 2019 Mar 15;124(6):822-824. doi: 10.1161/CIRCRESAHA.119.314753.

Authors

Mark L Ormiston¹, Rafael Soares Godoy², Ketul R Chaudhary², Duncan J Stewart²

Affiliations

¹ From the Departments of Biomedical and Molecular Sciences, Medicine and Surgery, Queen's University, Kingston, Ontario, Canada (M.L.O.).
² Ottawa Hospital Research Institute, Sinclair Centre for Regenerative Medicine and the University of Ottawa, Ontario, Canada (R.S.G., K.R.C., D.J.S.).

PMID: 30870124
DOI: 10.1161/CIRCRESAHA.119.314753

No abstract available

Keywords: BMPR-II receptor; Editorials; bone morphogenetic protein 9; endoglin; mutation; pulmonary hypertension.

Publication types

Editorial
Comment

MeSH terms

Familial Primary Pulmonary Hypertension
Growth Differentiation Factor 2
Humans
Hypertension, Pulmonary*
Pulmonary Arterial Hypertension*

Substances

Growth Differentiation Factor 2